MedTrace Logo

Impact of Transcutaneous Electrical Nerve Stimulation on the Autonomic Nervous System in the Treatment of Overactive Bladder

NCT07781033 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-08-24

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the impact of Transcutaneous Electrical Nerve Stimulation on the autonomic nervous system in adults women with overactive bladder.

The main question it aims to answer is :

Does Transcutaneous Electrical Nerve Stimulation to treat overactive bladder have an impact on the autonomic nervous system ?

To answer this question, the primary outcome measure will be heart rate variability (HRV) during transcutaneous electrical nerve stimulation therapy

Participants will:

* Receive their first and last sessions of transcutaneous electrical nerve stimulation in the hospital.
* Complete questionnaires during their first and last transcutaneous electrical nerve stimulation sessions.
* Have their heart rate variability measured during their first and last transcutaneous electrical nerve stimulation sessions.

Conditions

  • Overactive Bladder (OAB)

Interventions

OTHER

heart rate variability assement

Participants will: * Receive their first and last sessions of transcutaneous electrical nerve stimulation in the hospital. * Complete questionnaires during their first and last transcutaneous electrical nerve stimulation sessions. * Have their heart rate variability measured during their first and last transcutaneous electrical nerve stimulation sessions. These interventions are performed specifically as part of the study and are not part of routine care.

Sponsors & Collaborators

  • Centre Hospitalier de Roubaix

    lead OTHER

Principal Investigators

  • Guillaume Carnaux, physiotherapist specialized in · Centre Hospitalier Roubaix

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2028-10-01
Completion
2028-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07781033 on ClinicalTrials.gov